Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to -$22.8 million.

  • Orthofix Medical's Net Income towards Common Stockholders rose 1677.01% to -$22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$119.1 million, marking a year-over-year increase of 481.38%. This contributed to the annual value of -$126.0 million for FY2024, which is 2000.7% up from last year.
  • Orthofix Medical's Net Income towards Common Stockholders amounted to -$22.8 million in Q3 2025, which was up 1677.01% from -$14.1 million recorded in Q2 2025.
  • In the past 5 years, Orthofix Medical's Net Income towards Common Stockholders registered a high of $2.5 million during Q2 2022, and its lowest value of -$60.9 million during Q1 2023.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$27.4 million (2024), whereas its average is -$23.0 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 11313.5% in 2021, then crashed by 168400.96% in 2023.
  • Over the past 5 years, Orthofix Medical's Net Income towards Common Stockholders (Quarter) stood at -$32.8 million in 2021, then surged by 64.42% to -$11.7 million in 2022, then crashed by 142.32% to -$28.3 million in 2023, then dropped by 3.03% to -$29.1 million in 2024, then increased by 21.79% to -$22.8 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$22.8 million for Q3 2025, versus -$14.1 million for Q2 2025 and -$53.1 million for Q1 2025.